Search results
PayPal Stock's Earnings Surprise: Time to Bet on the Fintech Giant?
InvestorPlace· 6 hours agoPayPal (NASDAQ:PYPL) is favored in the current market. Despite slowing user growth, it remains...
Melissa J. Fleming
The National Law Review· 17 hours agoMelissa J. Fleming is a pre-settlement funding specialist who has dedicated her career to helping the plaintiffs in personal injury lawsuits to seek justice. Negotiating fair and adequate compensation ...
Betting on Zuck's Luck: Why Wall Street's Finest Are Going All-In on Meta Stock Ahead of Earnings
InvestorPlace· 7 days agoLong-term investors in Meta Platforms have been well-rewarded by holding. Here are two more reasons to buy META stock right now.
Crypto Carnage Ahead? 3 Tokens to Dump Before the Bloodbath
InvestorPlace· 13 hours agoUltimately, over the long term, the crypto projects likely to generate meaningful and sustainable...
Treasure Experience Welcomes Douglas Borthwick as Chief Investment Officer
Digital Journal· 11 hours agoAbout Douglas Borthwick: Douglas brings over three decades of finance expertise to Treasure Experience. As CMO of INX Limited, he was instrumental in...Douglas holds a BS ...
3 Penny Stocks to Buy Before Their Major Breakouts
InvestorPlace· 7 days agoIn the crowded penny stock market, identifying multi-bagger opportunities requires careful research to distinguish speculative from fundamentally strong...
DJT Stock Alert: Trump Media Calls for Congress to Investigate Stock 'Manipulation'
InvestorPlace· 6 days agoDon’t look now, but Trump Media (NASDAQ:DJT) is once again soaring. Shares of DJT stock are up...
Microsoft Earnings Preview: Watching AI’s Contribution To Azure (MSFT)
Seeking Alpha· 6 days agoThe valuation of Microsoft is always a worry, as it’s trading at 30x expected ’24 EPS for an...
Citi CEO says US consumers are more cautious, emphasizes bank overhaul
Reuters· 3 hours ago, opens new tab CEO Jane Fraser told shareholders on Tuesday that U.S. consumers are becoming more...
Stoke Therapeutics names new CFO amid growth phase By Investing.com
Investing.com· 1 day agoStoke Therapeutics, Inc. (NASDAQ:STOK), a biotechnology company focusing on RNA-based medicines for...
